a GPCR-coupled 7 transmembrane receptor that binds epinephrine and norepinephrine with approximately equal affinity. Mediates the catecholamine-induced activation of adenylate cyclase through the action of G proteins. Interacts with PIST and PSD-95. Localized at the plasma membrane and in the Golgi upon PIST overexpression. Homologous desensitization of the receptor is mediated by its phosphorylation by beta-adrenergic receptor kinase. Note: This description may include information from UniProtKB.
Protein type: GPCR, family 1; Membrane protein, integral; Membrane protein, multi-pass; Receptor, GPCR
Cellular Component: integral to plasma membrane; early endosome; plasma membrane; nucleus
Molecular Function: protein binding; protein heterodimerization activity; receptor signaling protein activity; dopamine binding; drug binding; norepinephrine binding; epinephrine binding; beta-adrenergic receptor activity; alpha-2A adrenergic receptor binding; Ras guanyl-nucleotide exchange factor activity; PDZ domain binding; beta1-adrenergic receptor activity
Biological Process: fear response; diet induced thermogenesis; negative regulation of multicellular organism growth; glycogen catabolic process; wound healing; apoptosis; positive regulation of apoptosis; adenylate cyclase activation; lipid homeostasis; positive regulation of systemic arterial blood pressure; regulation of calcium ion transport; sensory perception of pain; positive regulation of saliva secretion; Rho protein signal transduction; memory; regulation of inhibitory postsynaptic membrane potential; positive regulation of the force of heart contraction by norepinephrine; protein localization in organelle; heat generation; negative regulation of smooth muscle contraction; positive regulation of cAMP biosynthetic process; brown fat cell differentiation; response to cold; positive regulation of heart rate by epinephrine-norepinephrine; norepinephrine-epinephrine vasodilation involved in regulation of systemic arterial blood pressure; aging
LTP: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.